Verrucous epidermal nevi: some aspects of pathogenesis and clinical cases

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Verrucous epidermal nevi ― hamartomas of keratinocyte or epidermal appendages, located on the skin or mucous membranes in the form of isolated birthmarks, less often have a linear localization. The pathogenesis of verrucous epidermal nevi has not been fully defined, probably the development of the disease is associated with genetic mutations during embryogenesis and represent a special form of skin mosaicism. Verrucous epidermal nevi are skin pathologies that require attention as potentially dangerous in terms of the development of malignant neoplasms of the skin and due to the possible difficulties in their diagnosis and differential diagnosis.

Analysis of current data on the pathogenesis and differential diagnosis of various forms of verrucous epidermal nevi, presentation of clinical cases of verrucous epidermal nevi.

The article considers two clinical cases of linear verrucous epidermal nevus. Studies of the pathogenesis of WEN have shown the presence of changes in expressed proteins by affected skin cells, such as OGN, NT5C3A, ADD1, OLFML1, DHRS1, CALML5, SAMHD1, SFRP2, SPRR1B and SERPINB13. This may indicate the participation in the development of verrucous epidermal nevi of changes in the p53 signaling pathway, the cellular response to a cytokine stimulus, and disturbances in cell adhesion and differentiation of Th1 and Th2 cells. The presented clinical cases describe linear verrucous epidermal nevus in order to study the diagnosis of the disease, based on the clinical picture. The need for differential diagnosis of various forms of verrucous epidermal nevi is due to their clinical and sometimes histological similarity with other skin formations. Immunohistochemical examination, genetic analysis using sequencing of the affected skin exome, and proteomic analysis of proteins expressed by affected skin cells help to carry out differential diagnosis.

The study of the mechanisms of development of this disease will help not only in differential diagnosis with other skin diseases, but will also allow finding new approaches to its conservative therapy.

作者简介

Evgeniya Okladnikova

Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

编辑信件的主要联系方式.
Email: farmasis@yandex.ru
ORCID iD: 0000-0002-1909-222X
SPIN 代码: 1220-9302

MD, Associate Professor

俄罗斯联邦, Krasnoyarsk

Olga Selitskaya

Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Email: selickaya@inbox.ru
ORCID iD: 0000-0003-3960-1279
SPIN 代码: 1993-5439

MD, Associate Professor

俄罗斯联邦, Krasnoyarsk

参考

  1. Elmas ÖF, Akdeniz N. Dermoscopic aspect of verrucous epidermal nevi: New findings. Turk J Med Sci. 2019;49(3):710–714. doi: 10.3906/sag-1811-27
  2. Tlish MM, Sycheva NL, Avdienko IN, Faustov LA. Generalized verrucous epidermal nevus: the clinico-morphological diagnostic algorithm. Russian journal of Clinical dermatology and venereology. 2014;12(6):97–101. (In Russ). doi: 10.17116/klinderma2014697-101
  3. Ocampo-Garza J, Di Chiacchio NG, Haneke E, et al. Verrucous epidermal naevus: A misleading diagnosis for 28 years. J Eur Acad Dermatol Venereol. 2018;32(3):e109–e110. doi: 10.1111/jdv.14597
  4. Kouzak SS, Mendes MS, Costa IM. Cutaneous mosaicisms: Concepts, patterns and classifications. An Bras Dermatol. 2013;88(4):507–517. doi: 10.1590/abd1806-4841.20132015
  5. Jackson R. The lines of Blaschko. Br J Dermatol. 1976;96:349–359. doi: 10.1111/j.1365-2133.1976.tb00835.x
  6. Asch S, Sugarman JL. Epidermal nevus syndromes: New insights into whorls and swirls. Pediatr Dermatol. 2018;35(1):21–29. doi: 10.1111/pde.13273
  7. Atzmony L, Khan HM, Lim YH, et al. Second-hit, postzygotic PMVK and MVD mutations in linear porokeratosis. JAMA Dermatol. 2019;155(5):548–555. doi: 10.1001/jamadermatol.2019.0016
  8. Yarak S, Machado TY, Ogawa MM, et al. Squamous cell carcinoma arising in a multiple verrucous epidermal nevus. An Bras Dermatol. 2016;91(5 Suppl 1):166–168. doi: 10.1590/abd1806-4841.20164506
  9. Atzmony L, Ugwu N, Hamilton C, et al. Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders. Pediatr Dermatol. 2022;39(6):903–907. doi: 10.1111/pde.15094
  10. Riachi M, Polubothu S, Stadnik P, et al. Molecular genetic dissection of inflammatory linear verrucous epidermal naevus leads to successful targeted therapy. J Invest Dermatol. 2021;141(12):2979–2983.e1. doi: 10.1016/j.jid.2021.02.765
  11. Yuan T, Lu XH, Tang B Mr, et al. Differences in clinical characteristics and lesion proteomics between inflammatory linear verrucous epidermal nevus and local verrucous epidermal nevus. J Proteomics. 2022;260:104554. doi: 10.1016/j.jprot.2022.104554
  12. Tseng HW, Liao JB, Wei YA. Adult-onset inflammatory linear verrucous epidermal nevus: Immunohistochemical studies and review of the literature. J Cutan Pathol. 2021;48(1):140–146. doi: 10.1111/cup.13881
  13. Yuan T, Cai ML, Sheng YM, et al. Differentially expressed proteins identified by TMT proteomics analysis in children with verrucous epidermal naevi. J Eur Acad Dermatol Venereol. 2021;35(6):1393–1406. doi: 10.1111/jdv.17112
  14. Takeichi T, Suga Y, Mizuno T, et al. Recurrent KRT10 variant in ichthyosis with confetti. Acta Derm Venereol. 2020;100(14):adv00209. doi: 10.2340/00015555-3570
  15. Jordan CT, Cao L, Roberson ED, et al. PSORS2 is due to mutations in CARD14. Am J Hum Genet. 2012;90(5):784–795. doi: 10.1016/j.ajhg.2012.03.012
  16. Gyrylova SN, Aksenenko MB, Gavrilyuk DV, et al. Melanoma incidence mortality rates and clinico-pathological types in the siberian area of the Russian Federation. Asian Pac J Cancer Prev. 2014;15(5):2201–2204. doi: 10.7314/APJCP.2014.15.5.2201

补充文件

附件文件
动作
1. JATS XML
2. Fig. 1. Plaques with hyperkeratosis on the skin of the lumbar region along Blaschko’s lines (own observation).

下载 (423KB)
3. Fig. 2. Linear verrucous epidermal nevus on the skin of the back.

下载 (527KB)

版权所有 © Okladnikova E.V., Selitskaya O.V., 2022

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。
 


##common.cookie##